Fosun Pharma To Buy Gland Pharma for Up to $1.26 Billion

Updated on
  • Deal to be the biggest Indian asset purchase by a Chinese firm
  • Share trading to be resumed on Friday after one-day halt

Shanghai Fosun Pharmaceutical Group Co. plans to buy Indian drugmaker Gland Pharma Ltd. for no more than $1.26 billion.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.